Literature DB >> 1562654

Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients.

P H McWhinney1, C C Kibbler, S H Gillespie, S Patel, D Morrison, A V Hoffbrand, H G Prentice.   

Abstract

Stomatococcus mucilaginosus was isolated from eight neutropenic patients during nine febrile episodes over a 13-month period. Five of these isolates were from definite infections, including one case of fatal meningitis. This slime-producing, catalase-variable, gram-positive coccus is a component of the normal oral flora of humans. Its biochemical profile may result in misidentification; however, unlike most micrococci, it characteristically fails to grow on media containing 5% NaCl. All but one of our isolates were sensitive to benzylpenicillin, and all were sensitive to vancomycin. S. mucilaginosus may prove to be an important pathogen in severely immunocompromised patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562654     DOI: 10.1093/clinids/14.3.641

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

Review 1.  Miscellaneous catalase-negative, gram-positive cocci: emerging opportunists.

Authors:  Kathryn L Ruoff
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Rothia aeria acute bronchitis: the first reported case.

Authors:  J Michon; D Jeulin; J-M Lang; V Cattoir
Journal:  Infection       Date:  2010-04-01       Impact factor: 3.553

3.  A microbiological study of Papillon-Lefévre syndrome in two patients.

Authors:  K L Robertson; D B Drucker; J James; A S Blinkhorn; S Hamlet; P S Bird
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

4.  Rothia bacteremia: a 10-year experience at Mayo Clinic, Rochester, Minnesota.

Authors:  Poornima Ramanan; Jason N Barreto; Douglas R Osmon; Pritish K Tosh
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

Review 5.  Use of enzyme tests in characterization and identification of aerobic and facultatively anaerobic gram-positive cocci.

Authors:  S Bascomb; M Manafi
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

6.  Stomatococcus mucilaginosus produces a mannose-containing lipoglycan rather than lipoteichoic acid.

Authors:  I C Sutcliffe; L A Old
Journal:  Arch Microbiol       Date:  1995-01       Impact factor: 2.552

7.  Vertebral osteomyelitis with Stomatococcus mucilaginosus.

Authors:  H Nielsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

8.  Association of Stomatococcus mucilaginosus with cholangitis.

Authors:  V P Harjola; M Valtonen; A Sivonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

9.  Study of Stomatococcus mucilaginosus isolated in a hospital ward using phenotypic characterization.

Authors:  F H van Tiel; B F Slangen; H C Schouten; J A Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

10.  Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp.

Authors:  C von Eiff; M Herrmann; G Peters
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.